Drugs / Cycloferon
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06183229 | Sep 2023 → Mar 2024 | influenza | POLYSAN Scientific & Technological Pharmaceutical Company | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cycloferon | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06183229 ↗ |